Target intelligence / Profile preview

Human neural tissue and neural microenvironment

Molecular classification
Extracellular matrix, Cell adhesion molecules, Cytokines, Growth factors, Receptor, Ion channel, Other
01

Overview

The human neural tissue and neural microenvironment represent the complex, multicomponent system of the central nervous system (CNS), comprising neurons, glial cells (astrocytes, microglia, oligodendrocytes), the extracellular matrix (ECM), and the neurovascular unit (PubMed: 31534488). This microenvironment is critical for maintaining ionic homeostasis, providing metabolic support, and facilitating precise synaptic communication (PubMed: 30612051). It also serves as a protective barrier, with the blood-brain barrier regulating the entry of substances from the systemic circulation into the brain parenchyma. In pathological states such as neurodegeneration or malignancy, the microenvironment undergoes significant remodeling, often promoting chronic inflammation or protecting tumor cells from therapeutic agents (PubMed: 32839600). While not a single molecular target, the neural microenvironment is a focal point for therapeutic strategies aimed at neuroprotection and blood-brain barrier modulation. Drugs targeting this environment often focus on specific signaling pathways, such as those involving cytokines or growth factors, to restore physiological balance. Understanding the spatial and functional complexity of this system is vital for developing effective treatments for neurodegenerative and neuro-oncological conditions.

Other names
Central nervous system microenvironmentBrain microenvironmentNeurovascular unitNeural niche
02

Mechanism of action

Modulation of synaptic signaling, inhibition of neuroinflammation, and regulation of vascular permeability within the central nervous system.

03

Biological functions

Signal transductionCell deathImmune responseSynaptic transmissionHomeostasisNeuroprotectionBlood-brain barrier maintenanceOther
04

Disease associations

Neurodegenerative diseaseCancerInflammationStrokeOther
05

Safety considerations

NeurotoxicityBlood-brain barrier disruptionOff-target CNS effectsIntracranial pressure changes
06

Interacting drugs

Natalizumab

3 more in the full profile.

07

Biomarkers

Neurofilament light chain (NfL)Glial fibrillary acidic protein (GFAP)S100BAmyloid-beta

Beyond the preview

Go deeper on Human neural tissue and neural microenvironment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human neural tissue and neural microenvironment.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call